NEWS-INFO

Expanding Access to High-Quality Oral Solid Dosage Pharmaceuticals

At Innogenix, we are committed to delivering reliable, high-quality oral solid dosage pharmaceuticals that support healthcare providers, pharmacies, and patients across a broad range of therapeutic areas. Our growing portfolio includes tablets and capsules manufactured to meet stringent USP standards while offering flexible packaging configurations for institutional, retail, and unit-dose applications.

Comprehensive Oral Solid Dosage Portfolio

Our portfolio features a diverse selection of medications designed to address cardiovascular, neurological, psychiatric, gastrointestinal, and specialty care needs. Products are available in multiple strengths and pack sizes to support efficient dispensing and patient adherence.

Key Products Include:

Metronidazole Tablets, USP — available in 125 mg, 250 mg, and 500 mg strengths

Baclofen Tablets, USP — offered in 5 mg, 10 mg, and 20 mg strengths with bulk packaging options

Pilocarpine HCl Tablets, USP — available in 5 mg and 7.5 mg strengths

Labetalol HCl Tablets, USP — available in 100 mg, 200 mg, and 300 mg strengths

Metolazone Tablets, USP — available in 2.5 mg, 5 mg, and 10 mg strengths

Propranolol HCl Tablets, USP — ranging from 10 mg to 80 mg

Haloperidol Tablets, USP — available in multiple strengths from 0.5 mg to 20 mg

Captopril Tablets, USP — available from 12.5 mg through 100 mg

Ramelteon Tablets — 8 mg strength for sleep disorder management

Dofetilide Capsules — available in 0.125 mg, 0.25 mg, and 0.5 mg strengths

Flexible Packaging Solutions

To support varying distribution and dispensing needs, Innogenix offers both standard bottle packaging and blister unit-dose formats. Bulk pack sizes ranging from 100-count to 1000-count bottles help meet institutional and retail pharmacy requirements.

Our blister and unit-dose portfolio includes products such as:

Haloperidol Tablets

Baclofen Tablets

Captopril Tablets

Metronidazole Tablets

Metolazone Tablets

Blister packaging configurations are designed to improve medication organization, dosing accuracy, and patient compliance, making them ideal for hospitals, long-term care facilities, and outpatient settings.

Commitment to Quality and Reliability

Innogenix continues to focus on manufacturing excellence, regulatory compliance, and dependable supply chain support. By maintaining a broad and versatile product portfolio, we aim to provide healthcare partners with consistent access to essential medications in the formats they need most.

For more information about our product offerings, packaging configurations, or distribution opportunities, visit Innogenix or contact our team directly.

Zennova Pharmaceutical partners with Innogenix Pharmaceuticals

Zennova Pharma recently announced a partnership with Innogenix, a leading pharmaceutical company d in the United States. The collaboration grants Zennova varies of rights to access ten cutting-edge Rx products developed & under-developing by Innogenix, including the exclusive sales & marketing rights in greater China regions. This partnership also invites Zennova becoming a part of Innogenix Corporation's global supply chain, utilizing Zennova’s State-of-The-Art manufacturing facility in Chengdu, China.  The products covered under this agreement focus on critical healthcare areas such as sleep disorders and cardiovascular diseases, addressing vital gaps in medicines in both China and international markets.

This strategic partnership is an important milestone for Zennova Pharmaceuticals. In today's global landscape, collaborations between international pharmaceutical businesses have surged due to the industry's dynamic expansion and enhanced global market accessibility. As a result, focusing on both domestic and global pharmaceutical markets has become a widespread strategy to enhance international capabilities and overall competitiveness for growth.